US 11566236
Materials and methods for treatment of hemoglobinopathies
granted A61KA61K31/395A61K31/712
Quick answer
US patent 11566236 (Materials and methods for treatment of hemoglobinopathies) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/395, A61K31/712, A61K31/7125, A61K35/28